ORCASPO 50MG

Orcaspo 50mg Injection is an antifungal medication belonging to the echinocandin class, containing the active ingredient Caspofungin. It is indicated for the treatment of severe fungal infections in patients who either do not respond to or cannot tolerate alternative antifungal treatments. This injection is primarily utilized for invasive candidiasis, esophageal candidiasis, and invasive aspergillosis in both adult and pediatric populations.

Orcaspo 50mg Injection functions by inhibiting an enzyme necessary for the fungus to construct its cell wall. This action weakens the fungus, aiding the body in eliminating the infection. It is typically administered in a hospital setting by trained healthcare professionals via a slow intravenous drip.

The injection is contraindicated in individuals who are allergic to Caspofungin or any other components of the formulation. If you have a history of severe allergic reactions to antifungal medications, it is essential to inform your healthcare provider. Additionally, Orcaspo 50mg Injection may interact with medications such as cyclosporine, tacrolimus, and certain anti-seizure drugs, potentially increasing side effects or diminishing treatment effectiveness. Your physician may recommend blood tests to monitor liver and kidney function, particularly during prolonged use.

Prior to initiating treatment with Orcaspo 50mg Injection, it is important to inform your doctor if you have liver disease, are following a low-sodium diet, or have recently undergone surgery. If you are pregnant, planning to become pregnant, or breastfeeding, please notify your healthcare provider. Orcaspo 50mg Injection is administered under medical supervision, and the dosage may be adjusted based on factors such as weight, age, and the specific type of infection.